CLASS II ONGOING Drug recall · Reported 13 Jul 2022 · FDA Enforcement Report

Enalapril Maleate Tablets recalled by Golden State Medical Supply

Golden State Medical Supply is recalling Enalapril Maleate Tablets, USP, distributed nationwide in the US. The recall was initiated on 16 Mar 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLots: GS028301, 2.5 mg; 90 tablets, Exp.: 06/2022; Lots: GS029973, GS029974, GS031436, GS031715, GS033191, GS033940, Exp. : 10/2022; Lot: GS034212, Exp.: 12/2022; Lot: GS035315, GS035945, GS036905, GS038038, GS039199, Exp.: 04/2023; Lot: GS039200, GS040149, Exp.: 11/2023. (NDC: 60429-183-90).
NDC60429-183, 60429-184, 60429-185, 60429-186
Quantity recalled1,471 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1177-2022
FDA event ID
89863
Recalling firm
Golden State Medical Supply, Camarillo, CA
Manufacturer
Golden State Medical Supply, Inc.
Classification
Class II
Status
Ongoing
Recall initiated
16 Mar 2022
FDA classified
7 Jul 2022
Reported
13 Jul 2022
Type
Voluntary: Firm initiated
Customers notified by
Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Timeline

16 Mar 2022Recall initiated by company
7 Jul 2022Classified by FDA+113 days
13 Jul 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

CGMP Deviations

Product as listed by the FDA

Enalapril Maleate Tablets, USP; 2.5 mg; 90 tablets, NDC 60429-183-90; manufactured by Taro Pharmaceutical Industries, Ltd.; packaged by GSMS, Incorporated, CA, USA.

Where it was distributed

Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI

Nationwide HawaiiIllinoisMassachusettsNorth DakotaOhioPennsylvaniaTexas

Questions about this recall

Why was it recalled?

CGMP Deviations

Which lots are affected?

Lots: GS028301, 2.5 mg; 90 tablets, Exp.: 06/2022; Lots: GS029973, GS029974, GS031436, GS031715, GS033191, GS033940, Exp. : 10/2022; Lot: GS034212, Exp.: 12/2022; Lot: GS035315, GS035945, GS036905, GS038038, GS039199, Exp.: 04/2023; Lot: GS039200, GS040149, Exp.: 11/2023. (NDC: 60429-183-90).

Where was it sold?

Nationwide in the U.S: PA, MA, OH, TX, IL, ND, HI

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

3 other products · FDA event 89863

More recalls from Golden State Medical Supply

All 55

Other Enalapril recalls

All 21